taurolidine has been researched along with Inflammation in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Calvo, M; Coll, E; Compte, MT; Filella, X; Fontsere, N; Graterol, F; Jiménez Hernández, M; Maduell, F; Poch, E; Rebled, JM; Soriano, A | 1 |
Elsharkawy, M; Emara, A; Ezzat, H; Mansour, A; Mohsen, R; Rezk, K | 1 |
Foley, N; Jinih, M; Neary, PM; O'Connell, E; O'Leary, DP; Pfirrmann, RW; Redmond, HP; Wang, JH | 1 |
Campistol, JM; Cardozo, C; Donate, J; Fontseré, N; Maduell, F; Mensa, J; Muros, M; Navarro-González, JF; Pons, M; Soriano, A | 1 |
Biedroń, R; Bobek, M; Kontny, E; Kurnyta, M; Marcinkiewicz, J; Maśliński, W | 1 |
2 trial(s) available for taurolidine and Inflammation
Article | Year |
---|---|
Effect of taurolidine citrate and unfractionated heparin on inflammatory state and dialysis adequacy in hemodialysis patients.
Topics: Anticoagulants; C-Reactive Protein; Catheter-Related Infections; Central Venous Catheters; Citrates; Citric Acid; Heparin; Humans; Inflammation; Interleukin-6; Renal Dialysis | 2023 |
RandomiSed clinical trial assessing Use of an anti-inflammatoRy aGent in attenUating peri-operatiVe inflAmmatioN in non-meTastatic colon cancer - the S.U.R.G.U.V.A.N.T. trial.
Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Agents; Biomarkers; Chemotherapy, Adjuvant; Colectomy; Colonic Neoplasms; Female; Humans; Inflammation; Inflammation Mediators; Interleukin-6; Ireland; Male; Middle Aged; Neoplasm Recurrence, Local; Risk Factors; Surgical Wound Infection; Taurine; Thiadiazines; Time Factors; Treatment Outcome | 2018 |
3 other study(ies) available for taurolidine and Inflammation
Article | Year |
---|---|
Impact of locking solutions on conditioning biofilm formation in tunnelled haemodialysis catheters and inflammatory response activation.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Anticoagulants; Biofilms; Catheter-Related Infections; Catheters, Indwelling; Citric Acid; Equipment Design; Female; Heparin; Humans; Inflammation; Inflammation Mediators; Interleukin-6; Male; Microscopy, Confocal; Microscopy, Electron, Scanning; Middle Aged; Pilot Projects; Prospective Studies; Renal Dialysis; Surface Properties; Taurine; Thiadiazines; Time Factors; Treatment Outcome | 2021 |
Tunneled catheters with taurolidine-citrate-heparin lock solution significantly improve the inflammatory profile of hemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anticoagulants; C-Reactive Protein; Catheter-Related Infections; Central Venous Catheters; Citric Acid; Female; Heparin; Humans; Inflammation; Interleukin-10; Interleukin-6; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; RNA, Messenger; Taurine; Thiadiazines; Tumor Necrosis Factor-alpha | 2014 |
Anti-inflammatory effects of taurine derivatives (taurine chloramine, taurine bromamine, and taurolidine) are mediated by different mechanisms.
Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Chloramines; Enzyme Induction; Heme Oxygenase-1; Inflammation; Interferon-gamma; Interleukin-6; Macrophages, Peritoneal; Male; Mice; Mice, Inbred BALB C; Molecular Structure; Peritonitis; Taurine; Thiadiazines; Zymosan | 2006 |